Search Videos and More

Showing 1 - 12 of 116 results

Previous| 1 | 2 | 3 ...10 |Next


Dana-Farber Research News Archive News

Dana-Farber Research News Archive

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Dana-Farber Research News 12.1.2021 News

Dana-Farber Research News 12.1.2021

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
ASH 2021 Featured Oral Presentations Document

ASH 2021 Featured Oral Presentations

The Annual Meeting of the American Society of Hematology (ASH) will take place December 11-14th. To keep-up with latest advances, the live schedule of oral presentations by Dana-Farber faculty is attached for your convenience.
Targeted Drug Combination Shows Unprecedented Activity in Some Highly Aggressive Brain Tumors News

Targeted Drug Combination Shows Unprecedented Activity in Some Highly Aggressive Brain Tumors

Treatment with dabrafenib and trametinib yielded encouraging rate of durable responses in both high-grade and low-grade brain tumors carrying the rare BRAF v600E mutation. Study is first to show benefit of any targeted drugs in glioblastomas – the most aggressive brain tumor.
Discovery may lead to expanded donor pool for stem cell transplants for patients with cancer News

Discovery may lead to expanded donor pool for stem cell transplants for patients with cancer

Researchers find that in many cases people with a condition known as clonal hematopoiesis can safely serve as stem cell transplant donors.
Venetoclax Shown to Benefit Patients with Waldenström Macroglobulinemia, Including Some Who Relapsed After Previous Therapy News

Venetoclax Shown to Benefit Patients with Waldenström Macroglobulinemia, Including Some Who Relapsed After Previous Therapy

A drug that strips cancer cells of their quest for immortality represents an effective new option for patients with Waldenström macroglobulinemia, including those not helped by the only class of drugs currently approved to treat the disease, a clinical trial by Dana-Farber Cancer Institute investigators demonstrates.
Dana-Farber Cancer Institute Faculty Among World’s Most Highly Cited Researchers News

Dana-Farber Cancer Institute Faculty Among World’s Most Highly Cited Researchers

Dana-Farber Cancer Institute is proud to announce that 35 of its researchers have been named to the Highly Cited Researchers list of 2021 released today by the Institute for Scientific Information at Clarivate.
Papers Recount How Research Labs Learned to Work in Four-Part Harmony News

Papers Recount How Research Labs Learned to Work in Four-Part Harmony

A quartet of recent papers in the journal Clinical Cancer Research put the behind-the-scenes efforts involved in a major Moonshot project squarely on the record. The papers provide an inside look at some of the essential start-up activities of the Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC), a network of laboratories and a bioinformatics center established to perform the analytic work involved in developing new immunotherapies for cancer.
Survival Similar for Younger and Older Patients with Metastatic Colorectal Cancer, Study Finds News

Survival Similar for Younger and Older Patients with Metastatic Colorectal Cancer, Study Finds

Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.
Immunotherapy May Yield Longer Treatment-Free Survival than Targeted Therapy in Advanced Renal Cell Carcinoma Patients News

Immunotherapy May Yield Longer Treatment-Free Survival than Targeted Therapy in Advanced Renal Cell Carcinoma Patients

Analysis uses novel endpoint of treatment-free survival (TFS) to ‘better balance the efficacy and toxicity to patients’
Finding New Targets for Acute Myeloid Leukemia in Children News

Finding New Targets for Acute Myeloid Leukemia in Children

Looking for genes AML needs for everyday survival turned up two strong ‘hits’ to pursue for therapeutic development.
Rare Cancer: A Father's Journey with Medullary Kidney Cancer Video

Rare Cancer: A Father's Journey with Medullary Kidney Cancer

A father and Air Force recruiter details his journey at Dana-Farber Cancer Institute with medullary kidney cancer - a rare cancer disproportionately affecting African Americans.

Showing 1 - 12 of 116 results

Previous| 1 | 2 | 3 ...10 |Next